Answer
Ofatumumab (Kesimpta) is indicated for adults with relapsing forms of multiple sclerosis with active disease defined by clinical or imaging features.
Sources for this answer
- Kesimpta 20 mg solution for injection in pre-filled penNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked